BENEVICH ERIC
Insider CIK 1643653 · ATYR Director · NBIX Chief Commercial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NBIX NEUROCRINE BIOSCIENCES INC | F Tax w/h | 2026-09-11 | 2026-09-15 | 3,386 | $156.22 | $529.0K | 67,297 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award | 2026-09-11 | 2026-09-15 | 6,275 | — | $0 | 70,683 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | F Tax w/h | 2026-09-11 | 2026-09-15 | 3,386 | $156.22 | $529.0K | 67,297 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award | 2026-09-11 | 2026-09-15 | 6,275 | — | $0 | 70,683 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2026-09-09 | 2026-09-10 | 3,194 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2026-09-09 | 2026-09-10 | 2,154 | $154.61 | $333.0K | 64,408 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2026-09-09 | 2026-09-10 | 3,194 | $43.24 | $138.1K | 66,562 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2026-09-09 | 2026-09-10 | 3,194 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2026-09-09 | 2026-09-10 | 2,154 | $154.61 | $333.0K | 64,408 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2026-09-09 | 2026-09-10 | 3,194 | $43.24 | $138.1K | 66,562 | SEC↗ |
| ATYR aTYR PHARMA INC | A Award deriv | 2026-05-11 | 2026-05-13 | 50,000 | — | $0 | 50,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2026-02-13 | 2026-02-17 | 6,365 | — | $0 | 6,365 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2026-02-13 | 2026-02-17 | 1,961 | — | $0 | 3,924 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2026-02-13 | 2026-02-17 | 2,083 | — | $0 | 2,083 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2026-02-13 | 2026-02-17 | 36,287 | — | $0 | 36,287 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | F Tax w/h | 2026-02-13 | 2026-02-17 | 8,963 | $124.12 | $1.11M | 63,190 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award | 2026-02-13 | 2026-02-17 | 16,613 | — | $0 | 72,153 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | F Tax w/h | 2026-02-13 | 2026-02-17 | 1,124 | $124.12 | $139.5K | 55,540 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2026-02-13 | 2026-02-17 | 2,083 | — | $0 | 56,664 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | F Tax w/h | 2026-02-13 | 2026-02-17 | 1,058 | $124.12 | $131.3K | 54,581 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2026-02-13 | 2026-02-17 | 1,961 | — | $0 | 55,639 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2026-02-12 | 2026-02-17 | 2,005 | — | $0 | 6,017 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | F Tax w/h | 2026-02-12 | 2026-02-17 | 1,082 | $123.10 | $133.2K | 53,678 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2026-02-12 | 2026-02-17 | 2,005 | — | $0 | 54,760 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2026-01-31 | 2026-02-03 | 2,294 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | F Tax w/h | 2026-01-31 | 2026-02-03 | 1,292 | $136.06 | $175.8K | 52,755 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2026-01-31 | 2026-02-03 | 2,294 | — | $0 | 54,047 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2025-11-28 | 2026-01-16 | 12,830 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2025-11-28 | 2026-01-16 | 12,830 | $35.99 | $461.8K | 57,723 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2025-11-28 | 2025-12-02 | 5,970 | — | $0 | 6,860 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2025-11-28 | 2025-12-02 | 5,970 | $151.74 | $905.9K | 44,893 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2025-11-28 | 2025-12-02 | 5,970 | $35.99 | $214.9K | 50,863 | SEC↗ |
| ATYR aTYR PHARMA INC | A Award deriv | 2025-05-01 | 2025-05-02 | 50,000 | — | $0 | 50,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2025-02-13 | 2025-02-14 | 2,083 | — | $0 | 4,166 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2025-02-13 | 2025-02-14 | 1,961 | — | $0 | 5,885 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2025-02-13 | 2025-02-14 | 1,098 | $116.74 | $128.2K | 43,784 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2025-02-13 | 2025-02-14 | 1,961 | — | $0 | 45,745 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2025-02-13 | 2025-02-14 | 1,056 | $116.71 | $123.2K | 44,689 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2025-02-13 | 2025-02-14 | 2,083 | — | $0 | 44,882 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2025-02-12 | 2025-02-14 | 42,805 | — | $0 | 42,805 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2025-02-12 | 2025-02-14 | 8,022 | — | $0 | 8,022 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2025-02-10 | 2025-02-12 | 980 | $118.31 | $115.9K | 42,799 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2025-02-08 | 2025-02-12 | 1,860 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2025-02-08 | 2025-02-12 | 1,860 | — | $0 | 43,779 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2025-01-31 | 2025-02-04 | 2,294 | — | $0 | 2,294 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2025-01-31 | 2025-02-04 | 1,207 | $152.94 | $184.6K | 41,919 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2025-01-31 | 2025-02-04 | 2,294 | — | $0 | 43,126 | SEC↗ |
| ATYR aTYR PHARMA INC | A Award deriv | 2024-12-10 | 2024-12-12 | 100,000 | — | $0 | 100,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2024-04-15 | 2024-04-17 | 7,231 | $81.49 | $589.3K | 26,292 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2024-04-15 | 2024-04-17 | 12,587 | $81.05 | $1.02M | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-04-15 | 2024-04-17 | 12,587 | $133.36 | $1.68M | 40,778 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2024-04-15 | 2024-04-17 | 7,231 | $81.49 | $589.3K | 48,009 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-04-15 | 2024-04-17 | 7,231 | $133.36 | $964.3K | 40,778 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2024-04-15 | 2024-04-17 | 12,587 | $81.05 | $1.02M | 53,365 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2024-03-14 | 2024-03-15 | 5,479 | $79.02 | $433.0K | 33,881 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2024-03-14 | 2024-03-15 | 69,521 | $81.05 | $5.63M | 12,587 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-03-14 | 2024-03-15 | 69,521 | $139.38 | $9.69M | 40,778 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2024-03-14 | 2024-03-15 | 69,521 | $81.05 | $5.63M | 110,299 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-03-14 | 2024-03-15 | 5,479 | $139.38 | $763.7K | 40,778 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2024-03-14 | 2024-03-15 | 5,479 | $79.02 | $433.0K | 46,257 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2024-02-28 | 2024-02-29 | 53,143 | $43.24 | $2.30M | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2024-02-28 | 2024-02-29 | 21,857 | $79.02 | $1.73M | 39,360 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2024-02-28 | 2024-02-29 | 53,143 | $43.24 | $2.30M | 93,759 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2024-02-28 | 2024-02-29 | 21,857 | $79.02 | $1.73M | 62,473 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-02-28 | 2024-02-29 | 21,857 | $134.69 | $2.94M | 40,616 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-02-28 | 2024-02-29 | 53,143 | $134.69 | $7.16M | 40,616 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2024-02-13 | 2024-02-15 | 39,426 | — | $0 | 39,426 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2024-02-13 | 2024-02-15 | 7,846 | — | $0 | 7,846 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-02-13 | 2024-02-15 | 1,098 | $133.01 | $146.0K | 40,616 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-02-08 | 2024-02-08 | 980 | $134.19 | $131.5K | 39,631 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-02-06 | 2024-02-08 | 1,280 | $142.12 | $181.9K | 38,751 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-01-31 | 2024-02-02 | 1,207 | $140.78 | $169.9K | 37,601 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-08-21 | 2023-08-23 | 1,600 | $107.40 | $171.8K | 36,436 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2023-02-13 | 2023-02-15 | 51,782 | — | $0 | 51,782 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2023-02-13 | 2023-02-15 | 8,332 | — | $0 | 8,332 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-02-08 | 2023-02-08 | 980 | $104.12 | $102.0K | 34,381 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-02-07 | 2023-02-08 | 15,360 | $102.42 | $1.57M | 33,501 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-02-07 | 2023-02-08 | 2,030 | $102.29 | $207.6K | 19,705 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-02-06 | 2023-02-08 | 1,280 | $105.63 | $135.2K | 17,879 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-01-31 | 2023-02-02 | 1,207 | $109.95 | $132.7K | 16,729 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2023-01-06 | 2023-01-10 | 400 | $43.24 | $17.3K | 53,143 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-01-06 | 2023-01-10 | 400 | $125.00 | $50.0K | 15,643 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2023-01-06 | 2023-01-10 | 400 | $43.24 | $17.3K | 16,043 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2022-11-30 | 2022-12-01 | 20,063 | $43.24 | $867.5K | 53,543 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2022-11-30 | 2022-12-01 | 7,775 | $35.99 | $279.8K | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2022-11-30 | 2022-12-01 | 22,162 | $41.78 | $925.9K | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2022-11-30 | 2022-12-01 | 20,063 | $43.24 | $867.5K | 35,706 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2022-11-30 | 2022-12-01 | 7,775 | $125.90 | $978.9K | 15,643 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2022-11-30 | 2022-12-01 | 20,063 | $125.90 | $2.53M | 15,643 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2022-11-30 | 2022-12-01 | 22,162 | $125.90 | $2.79M | 15,643 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2022-11-30 | 2022-12-01 | 22,162 | $41.78 | $925.9K | 37,805 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2022-11-30 | 2022-12-01 | 7,775 | $35.99 | $279.8K | 23,418 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2022-11-10 | 2022-11-10 | 100 | $41.78 | $4.2K | 22,162 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2022-11-10 | 2022-11-10 | 100 | $125.36 | $12.5K | 15,643 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2022-11-10 | 2022-11-10 | 100 | $41.78 | $4.2K | 15,743 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2022-11-08 | 2022-11-10 | 24,593 | $41.78 | $1.03M | 22,262 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2022-11-08 | 2022-11-10 | 24,593 | $125.33 | $3.08M | 15,643 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2022-11-08 | 2022-11-10 | 24,593 | $41.78 | $1.03M | 40,236 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2022-11-03 | 2022-11-04 | 8,968 | $41.78 | $374.7K | 46,855 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2022-11-03 | 2022-11-04 | 8,968 | $41.78 | $374.7K | 24,611 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2022-11-03 | 2022-11-04 | 8,968 | $125.02 | $1.12M | 15,643 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2022-11-02 | 2022-11-04 | 400 | $41.78 | $16.7K | 55,823 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2022-11-02 | 2022-11-04 | 400 | $41.78 | $16.7K | 16,043 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2022-11-02 | 2022-11-04 | 400 | $125.00 | $50.0K | 15,643 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2022-10-17 | 2022-10-19 | 4,960 | $110.82 | $549.7K | 15,643 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2022-02-08 | 2022-02-09 | 980 | $79.67 | $78.1K | 20,338 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2022-02-07 | 2022-02-09 | 1,280 | $80.78 | $103.4K | 19,459 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2022-02-07 | 2022-02-09 | 809 | $80.68 | $65.3K | 16,483 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2022-02-07 | 2022-02-09 | 2,030 | $80.83 | $164.1K | 18,309 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2022-01-31 | 2022-02-02 | 62,483 | — | $0 | 62,483 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2022-01-31 | 2022-02-02 | 9,175 | — | $0 | 9,175 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2021-08-16 | 2021-08-18 | 5,628 | $89.62 | $504.4K | 15,608 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2021-02-08 | 2021-02-09 | 44,632 | — | $0 | 44,632 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2021-02-08 | 2021-02-09 | 7,439 | — | $0 | 7,439 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2021-02-08 | 2021-03-26 | 49,049 | — | $0 | 49,049 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2021-02-08 | 2021-02-09 | 845 | $116.89 | $98.8K | 18,018 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2021-02-08 | 2021-02-09 | 1,395 | $116.76 | $162.9K | 19,273 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2021-02-08 | 2021-02-09 | 2,030 | $116.84 | $237.2K | 21,099 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2021-02-05 | 2021-02-09 | 809 | $114.03 | $92.3K | 16,434 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2021-01-26 | 2021-01-27 | 300 | $41.78 | $12.5K | 56,223 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2021-01-26 | 2021-01-27 | 300 | $41.78 | $12.5K | 16,105 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2021-01-26 | 2021-01-27 | 300 | $120.00 | $36.0K | 15,805 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2021-01-26 | 2021-01-27 | 100 | $120.00 | $12.0K | 15,705 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2021-01-25 | 2021-01-27 | 3,477 | $41.78 | $145.3K | 56,523 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2021-01-25 | 2021-01-27 | 3,477 | $41.78 | $145.3K | 20,882 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2021-01-25 | 2021-01-27 | 3,477 | $120.03 | $417.3K | 17,405 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2021-01-25 | 2021-01-27 | 1,600 | $120.03 | $192.0K | 15,805 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2020-11-12 | 2020-11-16 | 2,257 | $90.71 | $204.7K | 17,405 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2020-11-02 | 2020-11-04 | 20,595 | $35.99 | $741.2K | 7,775 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2020-11-02 | 2020-11-04 | 20,595 | $96.53 | $1.99M | 15,374 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2020-11-02 | 2020-11-04 | 20,595 | $35.99 | $741.2K | 35,969 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2020-08-05 | 2020-08-07 | 2,257 | $118.85 | $268.2K | 15,374 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2020-04-24 | 2020-04-28 | 1,934 | $99.45 | $192.3K | 13,344 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2020-04-15 | 2020-04-17 | 8,632 | $94.65 | $817.0K | 11,603 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2020-02-07 | 2020-02-11 | 2,030 | $103.32 | $209.7K | 20,087 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2020-02-06 | 2020-02-07 | 9,719 | — | $0 | 9,719 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2020-02-06 | 2020-02-07 | 61,347 | — | $0 | 61,347 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2020-02-06 | 2020-02-07 | 1,395 | $101.48 | $141.6K | 18,262 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2020-02-05 | 2020-02-07 | 1,145 | $103.11 | $118.1K | 16,279 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2020-02-05 | 2020-02-07 | 809 | $102.90 | $83.2K | 17,007 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2019-07-15 | 2019-07-17 | 5,835 | $87.44 | $510.2K | 14,910 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2019-02-07 | 2019-02-08 | 83,341 | — | $0 | 83,341 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2019-02-07 | 2019-02-08 | 15,423 | — | $0 | 15,423 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2019-02-06 | 2019-02-08 | 920 | $83.57 | $76.9K | 20,745 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2019-02-05 | 2019-02-06 | 602 | $88.08 | $53.0K | 17,595 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2019-02-05 | 2019-02-06 | 755 | $87.95 | $66.4K | 19,015 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2018-06-01 | 2018-06-05 | 12,350 | $97.34 | $1.20M | 16,690 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | F Tax w/h | 2018-02-06 | 2018-02-07 | 917 | $82.48 | $75.6K | 4,310 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2018-02-05 | 2018-02-07 | 34,750 | — | $0 | 34,750 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2018-02-05 | 2018-02-07 | 6,150 | — | $0 | 6,150 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2018-02-05 | 2018-02-07 | 12,250 | — | $0 | 12,250 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2018-02-05 | 2018-02-07 | 820 | $83.14 | $68.2K | 2,577 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2017-02-07 | 2017-02-08 | 132 | $44.65 | $5.9K | 1,222 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2017-02-06 | 2017-02-08 | 10,600 | — | $0 | 10,600 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2017-02-06 | 2017-02-08 | 76,800 | — | $0 | 76,800 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2017-02-06 | 2017-02-08 | 821 | $43.11 | $35.4K | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2016-02-05 | 2016-02-09 | 41,200 | — | $0 | 41,200 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2016-02-05 | 2016-02-09 | 20,500 | — | $0 | 20,500 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2016-02-05 | 2016-02-09 | 8,700 | — | $0 | 8,700 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2015-06-01 | 2015-06-03 | 60,000 | — | $0 | 60,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2015-06-01 | 2015-06-03 | 25,000 | — | $0 | 25,000 | SEC↗ |